相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Cardiovascular Risks of Fostamatinib in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Yuehong Chen et al.
FRONTIERS IN PHARMACOLOGY (2021)
Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia
Ralph Boccia et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Efficacy and Safety of Multiple Dosages of Fostamatinib in Adult Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Yaqi Kang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Causes of Death in Rheumatoid Arthritis: How Do They Compare to the General Population?
Jessica Widdifield et al.
ARTHRITIS CARE & RESEARCH (2018)
Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management
Diederik De Cock et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2018)
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
Louise K. Mercer et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries
Johan Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Malignancy risk of anti-tumor necrosis factor alpha blockers: an overview of systematic reviews and meta-analyses
Yuehong Chen et al.
CLINICAL RHEUMATOLOGY (2016)
Comorbidities in rheumatoid arthritis
Maxime Dougados
CURRENT OPINION IN RHEUMATOLOGY (2016)
Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials
Sumit Kunwar et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Targeting Syk-activated B cells in murine and human chronic graft-versus-host disease
Ryan Flynn et al.
BLOOD (2015)
Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenstrom Macroglobulinemia
Isere Kuiatse et al.
CLINICAL CANCER RESEARCH (2015)
The Syk Inhibitor Fostamatinib Decreases the Severity of Colonic Mucosal Damage in a Rodent Model of Colitis
Guray Can et al.
JOURNAL OF CROHNS & COLITIS (2015)
Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Louise K. Mercer et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis
Teresa A. Simon et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis
Eva Salgado et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Involvement of the Syk-mTOR pathway in follicular lymphoma cell invasion and angiogenesis
S. Fruchon et al.
LEUKEMIA (2012)
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration
J. Hoellenriegel et al.
LEUKEMIA (2012)
The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice
Ingo Hilgendorf et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Spleen tyrosine kinase inhibition prevents chemokine- and integrin-mediated stromal protective effects in chronic lymphocytic leukemia
Maike Buchner et al.
BLOOD (2010)
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
Maite P. Quiroga et al.
BLOOD (2009)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
Allison L. Smitten et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
E Baecklund et al.
ARTHRITIS AND RHEUMATISM (2006)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
